Every Form 4 that NuSkin Enterprises, Inc. (NUS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NUS filings page.
Nu Skin Enterprises, Inc. (NUS) reported that director Edwina D. Woodbury acquired 22 shares of Class A Common Stock on September 9, 2026 through a grant or award transaction. The shares were credited at an effective price of $4.85 per share via dividend reinvestment under the company’s Deferred Compensation Plan.
After this acquisition, Ms. Woodbury directly holds a total of 62,474 shares of Nu Skin Class A Common Stock. No transactions were reported as made under a Rule 10b5-1 trading plan.
NU SKIN ENTERPRISES, INC. director Edwina D. Woodbury acquired 19 shares of Class A Common Stock at $5.43 per share through a dividend reinvestment under the Company's Deferred Compensation Plan. Following this plan-related award, she directly holds 62,452 shares of Class A Common Stock.
Nu Skin Enterprises director James M. Winett reported both an equity grant and a sale of Class A Common Stock. On June 1, 2026, he acquired 26,643 shares as a grant at $0.00 per share. On June 2, 2026, he executed an open-market sale of 7,203 shares at $5.62 per share pursuant to a Rule 10b5-1(c) trading plan adopted on November 11, 2025. After these transactions, he directly holds 37,448 shares of Nu Skin’s Class A Common Stock, indicating he retained a substantial position following the sale.
Nathanson Laura reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. director Laura Nathanson received a grant of 26,643 shares of Class A Common Stock on June 1, 2026. The shares were awarded at no purchase price, increasing her directly held stake to 57,116 shares after the transaction. This reflects compensation in equity rather than a market purchase.
Zorko Mark A reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. director Mark A. Zorko received a grant of 26,643 shares of Class A Common Stock on June 1, 2026 at no purchase price. Following this equity award, he directly holds 60,586 shares. This is a compensation-related grant, not an open-market trade.
NU SKIN ENTERPRISES, INC. director Edwina D. Woodbury reported both a sale and a stock grant of Class A Common Stock. On June 1, 2026, she executed an open-market sale of 7,203 shares at $5.70 per share. The same day, she acquired 26,643 shares through a grant or award at no stated purchase price. Following these transactions, her direct holdings totaled 62,433 shares of Class A Common Stock. The footnote states the sale occurred under a pre-arranged trading plan intended to comply with Rule 10b5-1(c) adopted on February 19, 2026, indicating the sale’s timing was planned in advance.
NU SKIN ENTERPRISES, INC. director Emma S. Battle received a grant of Class A Common Stock as equity compensation. She acquired 26,643 shares at a stated price of $0.0000 per share, increasing her direct holdings to 57,648 shares of Class A Common Stock following the transaction.
Thomas Pisano R. reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. director Thomas R. Pisano received a grant of Class A Common Stock as equity compensation. On June 1, 2026, he was awarded 26,643 shares at no purchase price, reflecting a stock-based award rather than an open-market buy. Following this grant, he directly holds 116,827 shares of Nu Skin Class A Common Stock, indicating the transaction increased his equity stake through a routine compensation-related award.
CAMPBELL DANIEL W reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. director Daniel W. Campbell received a grant of 26,643 shares of Class A Common Stock at no cash cost, increasing his direct holdings to 65,859 shares. He also has indirect ownership of 10,010 shares through a limited liability company he and his spouse own and control, and 53,375 shares through an irrevocable family trust.
Nu Skin Enterprises director Laura Nathanson reported an open-market sale of 2,676 shares of Class A Common Stock at $6.73 per share. After this transaction, she directly holds 30,473 shares. The sale represents a relatively small portion of her reported direct holdings.
NU SKIN ENTERPRISES director Edwina D. Woodbury acquired additional shares through a plan-related dividend reinvestment. On 2026-03-11, she received 14 shares of Class A Common Stock at $7.31 per share under the company’s Deferred Compensation Plan. Following this automatic, non-open-market transaction, she directly holds 42,993 shares.
Keisel Justin S reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. executive Justin S. Keisel, EVP and President of Global Sales, received a grant of 47,059 shares of Class A Common Stock. The award was recorded at a price of $0.00 per share, indicating an equity grant rather than an open-market purchase. Following this grant, Keisel directly holds 160,170 shares of Nu Skin Class A Common Stock.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett reported an equity award of 77,941 shares of Class A common stock on March 6, 2026. The shares were acquired as a grant with a reported price of $0.00 per share, indicating a non-cash award. Following this grant, Hatchett's directly held ownership increased to 260,818 shares of Nu Skin Class A common stock.
Nu Skin Enterprises executive Chayce David Clark received a large stock award that increases his direct ownership stake. On March 6, 2026, he was granted 138,971 shares of Nu Skin Class A Common Stock at no acquisition cost. After this grant, he directly owns 390,746 shares.
NU SKIN ENTERPRISES, INC. Chief Financial Officer Thomas James D received a grant of 114,706 shares of Class A Common Stock on March 6, 2026. The shares were awarded at a price of $0.00 per share, reflecting a stock grant rather than an open-market purchase.
Following this award, his directly held Class A Common Stock position increased to 267,102 shares. The transaction is coded as a grant, award, or other acquisition, indicating it was part of an equity award arrangement rather than a cash-funded transaction.
NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski reported receiving an equity grant of 282,353 shares of Class A Common Stock on March 6, 2026. The shares were acquired as a grant or award at a reported price of $0.00 per share. Following this award, his directly held stake increased to 1,001,905 Class A shares.
Nu Skin Enterprises executive Justin S. Keisel reported a tax-related share disposition. On February 26, 2026, 13,687 shares of Nu Skin Class A common stock were withheld at $8.63 per share to cover tax obligations from the vesting of previously granted restricted stock units.
After this non-open-market, tax-withholding disposition, Keisel’s direct holdings totaled 113,111 shares of Class A common stock. This type of transaction is administrative and tied to equity compensation rather than a discretionary share sale.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett had 26,001 shares of Class A common stock withheld on February 26, 2026 to cover tax obligations tied to vesting restricted stock units. These were recorded at $8.63 per share, leaving him with 182,877 shares held directly.
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 45,502 shares of Class A common stock were withheld at $8.63 per share to cover tax obligations. After this non‑open‑market withholding, Clark directly holds 251,775 shares of Nu Skin Enterprises Class A common stock.
Nu Skin Enterprises Chief Financial Officer Thomas James reported a Form 4 transaction involving Class A Common Stock. On February 26, 2026, 28,602 shares were disposed of at $8.63 per share through shares being withheld to cover tax obligations on previously vested restricted stock units. After this tax-withholding disposition, he directly held 152,396 shares of Nu Skin Enterprises Class A Common Stock.
Nu Skin Enterprises President and CEO Ryan S. Napierski reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 124,802 shares of Class A common stock were withheld at $8.63 per share to satisfy tax withholding obligations. After this non-market, tax-withholding disposition, he directly holds 719,552 shares of Nu Skin Class A common stock.
NU SKIN ENTERPRISES, INC. executive Justin S. Keisel reported a tax-related share disposition tied to equity compensation. On this Form 4, 1,534 shares of Class A Common Stock were withheld at $8.36 per share to cover tax obligations from vesting restricted stock units. After this non‑open‑market tax-withholding transaction, Keisel directly held 126,798 shares.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett reported a tax-withholding disposition of 10,763 shares of Class A common stock at $8.36 per share. These shares were withheld to cover tax obligations related to vesting restricted stock units. After this transaction, he directly holds 208,878 shares.
Nu Skin Enterprises EVP and General Counsel Chayce David Clark had 17,947 shares of Class A common stock withheld on a tax-withholding disposition. The shares, valued at $8.36 each, were used to satisfy tax obligations tied to vesting restricted stock units. After this transaction, he directly owned 297,277 shares.
Nu Skin Enterprises Chief Financial Officer Thomas James reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 11,725 shares of Class A common stock were withheld to cover tax obligations at $8.36 per share. After this tax-withholding disposition, he directly owns 180,998 shares of Nu Skin Enterprises Class A common stock.
Nu Skin Enterprises reported that President and CEO Ryan S. Napierski had 49,037 shares of Class A common stock withheld on February 15, 2026 to cover tax obligations from vesting restricted stock units. The shares were valued at $8.36 per share. After this tax-withholding disposition, he directly held 844,354 shares of Class A common stock.
Nu Skin Enterprises executive Justin S. Keisel reported stock awards tied to performance goals. On February 10, 2026, he acquired 2,910 shares of Class A common stock at $0.00 per share, increasing his direct holdings to 93,832 shares.
On the same date, he acquired an additional 34,500 shares at $0.00 per share, bringing his direct ownership to 128,332 shares. Both grants relate to previously awarded restricted stock units that became eligible for vesting after Nu Skin met specified performance criteria from 2024 and 2025 grants.
Nu Skin Enterprises' Chief Product Officer Steven Keith Hatchett reported stock awards tied to performance-based restricted stock units. On February 10, 2026, performance criteria were met for prior RSU grants, resulting in acquisitions of 8,952 and 43,124 shares of Class A Common Stock at $0.00 per share.
After these awards, Hatchett directly held a total of 219,641 Class A shares. The transactions are coded as grants or other acquisitions rather than open-market purchases.
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported stock awards tied to performance goals being met. On February 10, 2026, he acquired 15,667 Class A shares and another 75,466 Class A shares at $0.00 per share as performance-based restricted stock units became eligible for vesting. Following these awards, he directly holds 315,224 Class A shares.
Nu Skin Enterprises’ Chief Financial Officer James D. Thomas reported equity awards tied to performance goals being met. On February 10, 2026, he acquired 9,847 Class A common shares at $0.00 when 2024 performance-based restricted stock units became eligible to vest.
On the same date, 2025 performance-based restricted stock units also met their criteria, adding a further 47,436 Class A shares at $0.00. Following these grants, Thomas directly owned 192,723 Class A common shares, reflecting increased alignment with shareholders through stock-based compensation.
Nu Skin Enterprises President and CEO Ryan S. Napierski reported performance-based equity awards in Class A common stock. On February 10, 2026, he acquired 42,970 shares and 206,988 shares at a stated price of $0.00 per share through grants classified as awards or other acquisitions.
The Form 4 shows his directly held Class A common stock rising to 686,403 shares after the first transaction and 893,391 shares after the second. Footnotes explain these awards relate to restricted stock units granted in February 2024 and February 2025, which became eligible for vesting once Nu Skin met specified performance criteria on February 10, 2026.
Nu Skin Enterprises executive reports share withholding for taxes
Nu Skin Enterprises, Inc. officer Chayce Clark, who serves as EVP and General Counsel, reported a transaction in the company’s Class A common stock on 12/20/2025. A total of 9,049 shares were disposed of at a price of $10.27 per share, coded as an “F” transaction, which indicates shares were withheld by the company to satisfy tax withholding obligations tied to vesting of previously granted restricted stock units. After this tax-related withholding, Clark beneficially owned 224,091 shares of Nu Skin Class A common stock in direct ownership.
Nu Skin Enterprises director reports small share increase through plan dividend
A Nu Skin Enterprises, Inc. director filed a Form 4 reporting the acquisition of 10 shares of Class A common stock on 12/10/2025 at a price of $10.35 per share. The filing states these shares were acquired through dividend reinvestment under the company’s Deferred Compensation Plan in accordance with the plan’s terms. Following this transaction, the director beneficially owns 42,979 shares, held directly. This is a routine insider ownership update showing plan-based reinvestment rather than an open-market trade.
Nu Skin Enterprises (NUS) insider transaction: Chief Product Officer Steven Hatchett reported buying 5,500 shares of Class A Common Stock on 11/11/2025 at $9.61 per share, according to a Form 4 filing.
Following the purchase, Hatchett beneficially owns 167,565 shares, held directly. The filing was signed by attorney-in-fact Gregory Belliston on 11/12/2025.